Trial intelligence / Profile preview

Cyclosporine A + Punctal Plugs in SSDE

NCT07171710Enrolling by invitation

Sponsor
Tianjin Eye Hospital
Start
Mar 2024
Primary completion
Mar 2026
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Tianjin Eye Hospital. Primary endpoints: Ocular Surface Disease Index at 3 months, Visual Analog Scale at 3 months and 3 more. Started Mar 2024; status: enrolling by invitation.

Beyond the preview

Go deeper on NCT07171710.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07171710.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call